Bill Miller - Miller Value Partners
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 10,950 | 0.11 | $17.99 | ||
| 2024 Q2 | 10,950 | 0.12 | Reduce 5.60% | 0.01 | $16.26 |
| 2024 Q1 | 11,600 | 0.11 | Reduce 13.43% | 0.02 | $14.14 |
| 2023 Q4 | 13,400 | 0.09 | Reduce 5.80% | 0.01 | $10.45 |
| 2023 Q3 | 14,225 | 0.09 | Reduce 82.68% | 0.43 | $10.19 |
| 2023 Q2 | 82,137 | 0.42 | Reduce 97.91% | 19.67 | $7.52 |
| 2023 Q1 | 3,929,784 | 2.17 | Reduce 23.65% | 0.67 | $8.85 |
| 2022 Q4 | 5,147,027 | 3.03 | Reduce 44.39% | 2.42 | $9.12 |
| 2022 Q3 | 9,254,875 | 4.55 | Reduce 0.85% | 0.04 | $8.07 |
| 2022 Q2 | 9,334,590 | 3.93 | Reduce 7.20% | 0.30 | $7.52 |
| 2022 Q1 | 10,058,739 | 3.59 | Add 4.13% | 0.14 | $9.39 |
| 2021 Q4 | 9,659,519 | 2.74 | Reduce 0.91% | 0.03 | $8.01 |
| 2021 Q3 | 9,748,129 | 3.23 | Reduce 10.86% | 0.39 | $9.74 |
| 2021 Q2 | 10,935,783 | 2.82 | Add 3.62% | 0.10 | $9.90 |
| 2021 Q1 | 10,554,065 | 3.46 | Add 47.82% | 1.12 | $11.54 |
| 2020 Q4 | 7,139,700 | 2.31 | Reduce 11.79% | 0.31 | $9.65 |
| 2020 Q3 | 8,093,698 | 2.89 | Add 3.10% | 0.09 | $9.01 |
| 2020 Q2 | 7,850,472 | 4.30 | Reduce 0.86% | 0.04 | $12.33 |
| 2020 Q1 | 7,918,362 | 4.57 | Reduce 19.48% | 1.11 | $8.98 |
| 2019 Q4 | 9,834,067 | 3.45 | Add 15.82% | 0.47 | $9.80 |
| 2019 Q3 | 8,491,152 | 2.37 | Add 30.63% | 0.56 | $6.88 |
| 2019 Q2 | 6,500,252 | 2.40 | Add 43.10% | 0.72 | $9.23 |
| 2019 Q1 | 4,542,532 | 2.84 | Add 16.12% | 0.39 | $15.68 |
| 2018 Q4 | 3,911,802 | 2.76 | Add 0.16% | 0.00 | $15.42 |
| 2018 Q3 | 3,905,452 | 2.80 | Add 50.87% | 0.94 | $21.54 |
| 2018 Q2 | 2,588,612 | 2.42 | Add 17.93% | 0.37 | $24.32 |
| 2018 Q1 | 2,194,972 | 1.64 | Add 325.29% | 1.25 | $17.09 |
| 2017 Q4 | 516,112 | 0.43 | Buy | 0.43 | $18.95 |